Fabrication and evaluation of electrospun collagen/poly(N-isopropyl acrylamide)/chitosan mat as blood-contacting biomaterials for drug delivery

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 6, 2012, Pages 1421-1430

  Sundar, Saravanabhavan Shanmuga ^a   Sangeetha, Dharmalingam ^a  

^a ANNA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5-FLUOROURACIL; ANTICANCER DRUG; BLOOD COMPATIBILITY; BURST CONTROL; CANCER THERAPY; CHITOSAN CONCENTRATION; DRUG ENTRAPMENT; DRUG LOADING; ELECTROSPUN COLLAGEN; FIBER MATRIX; FIBER MORPHOLOGY; FIBER NETWORKS; HIGH SURFACE AREA; N-ISOPROPYLACRYLAMIDES; NANO-HYDROXYAPATITE; POTENTIAL APPLICATIONS; RELEASE KINETICS; SIMULATED BODY FLUIDS;

AMIDES; BIOLOGICAL MATERIALS; BIOMATERIALS; BLOOD; DRUG DELIVERY; ELECTROSPINNING; HYDROXYAPATITE; LOADING; MORPHOLOGY;

CHITOSAN;

BIOMATERIAL; CHITOSAN; COLLAGEN; FLUOROURACIL; HYDROXYAPATITE; POLY(N ISOPROPYL ACRYLAMIDE); UNCLASSIFIED DRUG;

ARTICLE; BLOOD COMPATIBILITY; BODY FLUID; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTROSPINNING; FIBER; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; KINETICS; MORPHOLOGY; NANOFABRICATION; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPE; THROMBOGENICITY;

ACRYLAMIDES; ANIMALS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; CELL LINE; CELL SURVIVAL; CHITOSAN; COLLAGEN; DRUG DELIVERY SYSTEMS; FLUOROURACIL; HELA CELLS; HUMANS; MATERIALS TESTING; MICE; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; POLYMERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEXTILES;

EID: 84863330589     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4610-x     Document Type: Article

References (37)

1. Kakinoki S, Taguchi T, Saito H, Tanaka J, Tateishi T. Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: characterization and in vitro evaluation. Eur J Pharm Biopharm. 2007;66:383-90. (Pubitemid 46756224)
2. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75:1-18.
3. Cai L, Qiu N, Li X, Luo K, Chen X, Yang L, He G, Wei Y, Che L. A novel truncated basic fibroblast growth factor fragmentconjugated poly(ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells. Int J Pharm. 2011;408:173-82.
4. Sumanta KS, Sanjay KM, Susmita S, Tapas KM, Sudip KG, Panchanan P. In vitro evaluation of folic acid modified carboxy methyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J Mater Sci Mater Med. 2010;21:1587-97. doi: 10.1007/s10856-010-3998-4.
5. Luu YK, Kim K, Hsiao BS, Chu B, Hadjiargyrou M. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release. 2003;89:341-53. (Pubitemid 36507026)
6. Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res. 2002;60:613-21. (Pubitemid 34492600)
7. Matthews JA, Boland ED, Wnek GE, Simpson DG, Bowlin GL. Electrospinning of collagen type II: a feasibility study. J Bioact Compat Polym. 2003;18:125-34. (Pubitemid 36745109)
8. Franco RA, Nguyen TH, Lee B. Preparation and characterization of electrospun PCL/PLGA membranes and chitosan/gelatin hydrogels for skin bioengineering applications. J Mater Sci Mater Med. 2011;22:2207-18.
9. Toshkova R, Manolova N, Gardeva E, Ignatova M, Yossifova L, Rashkov I, Alexandrov M. Antitumor activity of quaternized chitosan-based electrospun implants against Graffi myeloid tumor. Int J Pharm. 2010;400:221-33.
10. Chew SY, Wen J, Yim EKF, Leong KW. Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules. 2005;6:2017-24. (Pubitemid 41052194)
11. Kenawy ER, Bowlin GL, Mansfield K, Layman J, Simpson DG, Sanders EH, Wnek GE. Release of tetracycline hydrochloride from electrospun poly(ethylene-co- vinyl acetate), poly-(lactic acid), and a blend. J Control Release. 2002;81: 57-64. (Pubitemid 34454849)
12. Zeng J, Xu X, Chen X, Liang Q, Bian X, Yang L, Jing X. Biodegradable electrospun fibers for drug delivery. J Control Release. 2003;92:227-31. (Pubitemid 38366145)
13. Wu H, Fan J, Chu C, Wu J. Electrospinning of small diameter 3-D nanofibrous tubular scaffolds with controllable nanofiber orientations for vascular grafts. J Mater Sci Mater Med. 2010;21:3207-15. doi:10.1007/s10856-010- 4164-8.
14. Xu J, Jiao Y, Shao X, Zhou C. Controlled dual release of hydrophobic and hydrophilic drugs from electrospun poly(L-lactic acid) fiber mats loaded with chitosan microspheres. Mater Lett. 2011;65:2800-3.
15. Berkland C, King M, Cox A, Kim K, Pack DW. Precise control of PLG microsphere size provides enhanced control of drug release rate. J Control Release. 2002;82:137-47. (Pubitemid 34775055)
16. Zeng J, Yang L, Liang Q, Zhang X, Guan H, Xu X, Chen X, Jing X. Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation. J Control Release. 2005;105:43-51. (Pubitemid 40805474)
17. Manconi M, Mura S, Manca ML, Fadda AM, Dolz M, Hernandez MJ, Casanovas A, Diez-Sales O. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization. Int J Pharm. 2010;392:92-100.
18. Mi FL, Shyu SS, Wu YB, Lee ST, Shyong JY, Huang RN. Fabrication and characterization of a sponge-like assymetric chitosan membrane as a wound dressing. Biomaterials. 2001;22:165-73.
19. Zahedi P, De Souza R, Piquette-Miller M, Allen C. Chitosanphospholipid blend for sustained and localized delivery of docetaxel to the peritoneal cavity. Int J Pharm. 2009;377:76-84.
20. Friess W. Collagen-biomaterial for drug delivery. Eur J Pharm Biopharm. 1998;45:113-36.
21. Zhao J, Han W, Chen H, Tu M, Huan S, Miao G, Zeng R, Wu H, Cha Z, Zhou C. Fabrication and in vivo osteogenesis of biomimetic poly(propylene carbonate) scaffold with nanofibrous chitosan network in macropores for bone tissue engineering. J Mater Sci Mater Med. 2011;. doi:10.1007/s10856-011-4468-3.
22. Enea D, Henson F, Kew S, Wardale J, Getgood A, Brooks R, Rushton N. Extruded collagen fibres for tissue engineering applications: effect of crosslinking method on mechanical and biological properties. J Mater Sci Mater Med. 2011;22:1569-78. doi:10.1007/s10856-011-4336-1.
23. Lee SB, Ha DI, Cho SK, Kim SJ, Lee YM. Temperature/pH-sensitive comb-type graft hydrogels composed of chitosan and poly(Nisopropylacrylamide). J Appl Polym Sci. 2004;92:2612-20. (Pubitemid 38476136)
24. Zeng P, Xu Y, Zeng C, Ren H, Peng M. Chitosan-modified poly(D, L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int J Pharm. 2011;415:259-66.
25. Khor E. Methods for the treatment of collagenous tissues for bioprostheses. Biomaterials. 1997;18:95-105. (Pubitemid 27033943)
26. Oliver RF, Grant RA, Cox RW, Cooke A. Effect of aldehyde crosslinking on human dermal collagen implants in the rat. Br J Exp Path. 1980;61:544-9.
27. Goppert TM, Muller RH. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. Int J Pharm. 2005;302:172-86. (Pubitemid 41242762)
28. Jain SK, Chaurasiya A, Gupta Y, Jain A, Dagur P, Joshi B, Katoch VM. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting. J Microencapsul. 2008;25:289-97. (Pubitemid 352025005)
29. El-Ghannam A, Ricci K, Malkawi A, Jahed K, Vedantham K, Wyan H, Allen LD, Dreau D. A ceramic-based anticancer drug delivery system to treat breast cancer. J Mater Sci Mater Med. 2010;21:2701-10. doi:10.1007/s10856-010-4121-6.
30. Phillips TA, Howell A, Grieve RJ, Welling PG. Pharmacokinetics of oral and intravenous 5-fluorouracil in humans. J Pharm Sci. 1980;69:1428-31. (Pubitemid 11172827)
31. Chen X, Yang Y, Yao J, Lin W, Li Y, Chen Y, Gao Y, Yang Y, Gu X, Wang X. Bone marrow stromal cells-loaded chitosan conduits promote repair of complete transection injury in rat spinal cord. J Mater Sci Mater Med. 2011;22:2347-56. doi: 10.1007/s10856-011-4401-9.
32. Gopal VS, Usha YN, Sreenivasa MR, Karthik A, Praful BD, Ranjith Kumar A, Udupa N. Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation. J Mater Sci Mater Med. 2011;22:865-78. doi:10.1007/s10856-011-4274-y.
33. He Q, Ao Q, Gong Y, Zhang X. Preparation of chitosan films using different neutralizing solutions to improve endothelial cell compatibility. J Mater Sci Mater Med. 2011;22:2791-802. doi: 10.1007/s10856-011-4444-y.
34. Kong L, Gao Y, Lu G, Gong Y, Zhao N, Zhang X. A study on the bioactivity of Chitosan/nano-hydroxyapatite composite scaffolds for bone tissue engineering. Eur Polymer J. 2006;42:31771-3179.
35. Wang Q, Hu X, Du Y, Kennedy JF. Alginate/starch blend fibers and their properties for drug controlled release. Carbohydr Polym. 2010;82:842-7.
36. Stemberger A, Ascherl R, Blumel G. Kollagen, Ein. Biomaterial in Der Medizin. Hamostaseologie. 1990;10:164-76.
37. Beena MS, Chandy T, Sharma CP. Heparin immobilized chitosan- polyethylene glycol interpenetrating network: antithrombogenicity. Artif Cells Blood Subs Immob Biotech. 1995;23:175-92.